Xoma Royalty Corporation's ability to collect accounts receivable sequentially worsen to 13.05, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Average collection period, for Xoma Royalty's accounts receivable remained unchanged at 28 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 83 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 902, from overall ranking in the fourth quarter 2025 at 2543.

What is Receivable Turnover Ratio?
What is Xoma Royalty Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

XOMA Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-17.12 %	166.23 %	241.91 %	245.44 %	184700 %
Y / Y Revenue Change	-22.59 %	57.87 %	29.93 %	18.43 %	967.92 %
Receivable Turnover Ratio (TTM)	13.05	13.18	14.75	17.55	19.17
XOMA's Total Ranking	# 902	# 2543	# 2629	# 531	# 2530
Accounts Receivable average collection period days	28	28	25	21	19
Seq. Receivable Change	-6.15 %	37.03 %	96.64 %	-67.23 %	201.47 %
Seq. Revenue Change	-10.46 %	47.12 %	-28.78 %	-17.49 %	82.6 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 34
Healthcare Sector	# 84
Overall Market	# 902

Receivable Turnover Ratio Statistics
High	Average	Low
635.06	60.62	0.96
(Sep 30 2022)		(Sep 30 2015)

XOMA Company Profile • Back to XOMA Efficiency Comparisons • Compare XOMA Receivables Turnover Ratio to its Competitors

Financial Statements
Xoma Royalty's Accounts Receivable	$ 5 Millions	Visit XOMA's Balance sheet
Xoma Royalty's Sales TTM	$ 49 Millions	Visit XOMA's Income Statement
Sources of XOMA's Revenues		Visit XOMA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
XOMA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
XOMA's Growth Rates	XOMA's Roa	XOMA's Inventory Turnover Ratio	XOMA's Dividend Comparisons
XOMA's Profitability Ratios	XOMA's Roi	XOMA's Asset Turnover Ratio	XOMA's Dividend Growth
XOMA's Valuation Ratios	XOMA's Roe	XOMA's Financial Strength Ratios	XOMA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Marpai Inc	29.03	$ 17.125 Millions	$ 0.590 Millions
Lineage Cell Therapeutics Inc	28.42	$ 14.779 Millions	$ 0.520 Millions
Jaguar Health Inc	28.17	$ 29.569 Millions	$ 1.050 Millions
Meiragtx Holdings Plc	28.01	$ 79.758 Millions	$ 2.848 Millions
Cv Sciences Inc	27.37	$ 11.925 Millions	$ 0.436 Millions
Wave Life Sciences Ltd	27.36	$ 88.173 Millions	$ 3.223 Millions
Safe Pro Group Inc	27.29	$ 1.642 Millions	$ 0.060 Millions
Atara Biotherapeutics Inc	27.03	$ 23.540 Millions	$ 0.871 Millions
Biorestorative Therapies Inc	25.41	$ 0.363 Millions	$ 0.014 Millions
Kiniksa Pharmaceuticals International Plc	24.63	$ 754.045 Millions	$ 30.618 Millions
Polomar Health Services, Inc.	24.47	$ 1.649 Millions	$ 0.067 Millions
Igc Pharma Inc	23.44	$ 1.166 Millions	$ 0.050 Millions
Cytomx Therapeutics Inc	23.09	$ 35.542 Millions	$ 1.539 Millions
Siga Technologies Inc	22.41	$ 93.777 Millions	$ 4.186 Millions
Ataibeckley Inc	21.56	$ 3.488 Millions	$ 0.162 Millions
Fonar Corporation	21.15	$ 105.338 Millions	$ 4.981 Millions
Neuraxis Inc	20.94	$ 4.282 Millions	$ 0.204 Millions
Vystar Corporation	20.58	$ 0.048 Millions	$ 0.002 Millions
Lifemd Inc	19.91	$ 177.869 Millions	$ 8.934 Millions
Longeveron Inc	19.07	$ 1.216 Millions	$ 0.064 Millions
Premier Air Charter Holdings Inc	18.93	$ 33.205 Millions	$ 1.754 Millions
Sonida Senior Living Inc	18.82	$ 411.850 Millions	$ 21.878 Millions
Voyager Therapeutics Inc	17.99	$ 36.494 Millions	$ 2.029 Millions
China Pharma Holdings Inc	17.15	$ 3.992 Millions	$ 0.233 Millions
Nutriband Inc	16.79	$ 1.803 Millions	$ 0.107 Millions
Bioage Labs Inc	15.90	$ 10.316 Millions	$ 0.649 Millions
Arvinas Inc	15.15	$ 89.400 Millions	$ 5.900 Millions
Nurix Therapeutics Inc	15.11	$ 71.779 Millions	$ 4.750 Millions
Lexicon Pharmaceuticals Inc	14.91	$ 69.643 Millions	$ 4.670 Millions
Vaxart Inc	14.88	$ 255.609 Millions	$ 17.175 Millions

Date modified: 2026-09-18T13:11:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.